CG MedTech Co.,Ltd. (KOSDAQ:056090)
South Korea · Delayed Price · Currency is KRW 2,165.00
0.00 (0.00%)
At close: Feb 19, 2026
CG MedTech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 3,849 | 59.69 | 1,629 | -18,540 | -4,970 | -12,283 |
Depreciation & Amortization | 1,866 | 1,692 | 1,853 | 2,201 | 2,162 | 2,406 |
Loss (Gain) From Sale of Assets | -223.22 | -148.27 | -261.96 | -165.77 | -23.41 | 5.03 |
Asset Writedown & Restructuring Costs | - | - | 463.9 | - | 3,944 | - |
Loss (Gain) From Sale of Investments | 401.35 | 258.52 | 340.46 | -672.25 | -191.93 | 166.86 |
Stock-Based Compensation | - | 75.42 | 59.62 | 9.54 | - | - |
Provision & Write-off of Bad Debts | 645.55 | 202.99 | -3,918 | 126.82 | -107.26 | -124.16 |
Other Operating Activities | -1,751 | -2,226 | -1,365 | 18,953 | 619.7 | 9,454 |
Change in Accounts Receivable | -686.44 | 1,412 | 1,042 | -796.73 | 328.9 | 2,199 |
Change in Inventory | -2,152 | 1,546 | 613.45 | 152.11 | -645.64 | -694.71 |
Change in Accounts Payable | 40.44 | 336.52 | 281.19 | -1,733 | 604.71 | -55.76 |
Change in Other Net Operating Assets | -1,388 | -1,698 | -3,216 | -4,900 | -483.38 | 1,077 |
Operating Cash Flow | 602.18 | 1,511 | -2,478 | -5,365 | 1,237 | 2,150 |
Operating Cash Flow Growth | -76.35% | - | - | - | -42.45% | - |
Capital Expenditures | -5,195 | -773.97 | -1,590 | -819.5 | -862.16 | -204.69 |
Sale of Property, Plant & Equipment | 309.84 | 333.04 | 340.24 | 295.59 | 506.17 | 49.76 |
Cash Acquisitions | -8,462 | -3,084 | - | - | -1,597 | - |
Sale (Purchase) of Intangibles | -100.37 | -36 | -55.16 | -4.89 | -368.2 | -26.79 |
Investment in Securities | 5,246 | -5,640 | 56,461 | -52,696 | -3,205 | -2,012 |
Other Investing Activities | 130 | 113.69 | 18.12 | 201.9 | 204.99 | 21.5 |
Investing Cash Flow | -7,915 | -8,950 | 55,025 | -52,255 | -4,651 | -1,620 |
Short-Term Debt Issued | - | 360 | 700 | 81.31 | 596.15 | 1,550 |
Long-Term Debt Issued | - | - | - | 70,100 | 10,948 | 3,000 |
Total Debt Issued | 360 | 360 | 700 | 70,181 | 11,544 | 4,550 |
Short-Term Debt Repaid | - | -399.8 | - | -11,087 | -788.88 | -3,106 |
Long-Term Debt Repaid | - | -856.34 | -63,258 | -15,387 | -334.29 | -569.38 |
Total Debt Repaid | -4,236 | -1,256 | -63,258 | -26,475 | -1,123 | -3,675 |
Net Debt Issued (Repaid) | -3,876 | -896.14 | -62,558 | 43,707 | 10,421 | 875.08 |
Issuance of Common Stock | 11,968 | 22,325 | - | 24,179 | - | - |
Other Financing Activities | -202.1 | -52.05 | -0 | 0 | -0 | -0 |
Financing Cash Flow | 7,889 | 21,377 | -62,558 | 67,886 | 10,421 | 875.08 |
Foreign Exchange Rate Adjustments | 147.85 | 352.88 | 160.63 | -102.77 | 238.55 | -196.57 |
Net Cash Flow | 724.11 | 14,290 | -9,851 | 10,163 | 7,245 | 1,208 |
Free Cash Flow | -4,592 | 736.7 | -4,068 | -6,184 | 375.08 | 1,945 |
Free Cash Flow Growth | - | - | - | - | -80.72% | - |
Free Cash Flow Margin | -10.07% | 2.13% | -11.63% | -15.02% | 0.99% | 7.00% |
Free Cash Flow Per Share | -38.90 | 7.85 | -51.58 | -92.95 | 8.43 | 50.70 |
Cash Interest Paid | 268.1 | 207.98 | 144.01 | 1,869 | 352.3 | 299.56 |
Cash Income Tax Paid | 301.2 | -6.7 | -12.78 | 305.71 | 40.48 | 238.49 |
Levered Free Cash Flow | -343.93 | 4,127 | -460.1 | -9,617 | 766.1 | 4,459 |
Unlevered Free Cash Flow | -227.86 | 4,243 | -125.17 | -5,668 | 1,575 | 5,235 |
Change in Working Capital | -4,185 | 1,596 | -1,279 | -7,277 | -195.4 | 2,525 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.